Pharmacovigilance and Drug Safety Software Market - 50% of Growth to Originate from North America | Evolving Opportunities with AB Cube SARL & Oracle Corp.| Technavio

For more insights on the market share of various regions - Download a sample report in MINUTES

Read the 120-page report with TOC on "Pharmacovigilance and Drug Safety Software Market Analysis Report by End-user (Pharmaceutical and biotechnology companies, Contract research organization, and Business process outsourcing) and Geography (North America, Europe, Asia, and Rest of World (ROW)), and the Segment Forecasts,2022-2026". Gain competitive intelligence about market leaders. Track key industry opportunities, trends and threats. Information on marketing, brand, strategy and market development, sales, and supply functions. https://www.technavio.com/report/report/pharmacovigilance-and-drug-safety-software-market-industry-analysis

 Pharmacovigilance and Drug Safety Software Market: Vendor Analysis

The pharmacovigilance and drug safety software market is fragmented and the vendors are deploying growth strategies such as focusing on software innovations and are increasing existing software capabilities to expand their presence and share in the market to compete in the market. The pharmacovigilance and drug safety software market report offer information on several market vendors, including AB Cube SARL, Accenture Plc, Advera Health Analytics Inc., ArisGlobal LLC, BaseCon AS, Clarivate PLC, Cognizant Technology Solutions Corp., Ennov, EXTEDO GmbH, Honeywell International Inc., Indegene Pvt. Ltd., IQVIA Holdings Inc., Max Application Srl, Oracle Corp., Pegasystems Inc., Sarjen Systems Pvt. Ltd., United BioSource LLC, Veeva Systems Inc., and Wipro Ltd. among others.

• AB Cube SARL - The company offers pharmacovigilance and drug safety software namely SafetyEasy Suite which is a multi-vigilance management solution that integrates automation with existing drug safety processes.

To know about all major vendor offerings - Download a sample now!

Pharmacovigilance and Drug Safety Software Market: Drivers & Challenges

The key factor driving growth in the pharmacovigilance and drug safety software market is the rising incidence rates of adverse drug events. There has been a global surge in the incidence of unwanted and undesirable effects of drugs during their clinical use. This can be attributed to the rising consumption of drugs worldwide and the unwanted medical occurrence and side effects during the treatment, which can result in the discontinuation or modification of drugs. This is a major concern for pharmaceutical manufacturers. Fast adoption of pharmacovigilance and drug safety software products among pharmaceutical and life science manufacturers has been observed owing to the increasing incidence of adverse drug events. The rising geriatric population is expected to further boost the number of patients encountering adverse drug events, which will create a rise in demand for pharmacovigilance and drug safety software. This increase in the geriatric population is anticipated to surge the incidence of adverse drug events, which will positively impact the demand for drug safety software.

However, the high cost of ownership, installation, and maintenance will be a major challenge for the pharmacovigilance and drug safety software market during the forecast period. The cost involved in the on-premises and cloud-based software solutions can be categorized into three major categories: initial capital cost (initial cost), deployment cost, and maintenance cost (ongoing and ongoing personnel cost). All these categories are combined to form the total deployment cost. The low adoption of pharmacovigilance and data safety software among small- and medium-scale business enterprises can be observed across the market due to the high ownership, installation, and maintenance costs. The cost of ownership of on-premises software is even higher than cloud-based solutions. On-premises software for pharmacovigilance and drug safety also involves the cost of hardware, network, facility, and security, which makes them highly-priced in the market. Small-scale pharmaceutical manufacturers who do not rely on large volumes of drug safety solutions restrict them towards the purchase of personnel drug safety software, which hampers the market growth.

To know about other drivers & challenges - Download a sample now!

Pharmacovigilance And Drug Safety Software Market: Segmentation Analysis

End-user Outlook (Revenue, USD mn, 2021-2026)

• Pharmaceutical and biotechnology companies - size and forecast 2021-2026
• Contract research organization - size and forecast 2021-2026
• Business process outsourcing - size and forecast 2021-2026

Geography Outlook (Revenue, USD mn, 2021-2026)

• North America - size and forecast 2021-2026
• Europe - size and forecast 2021-2026
• Asia - size and forecast 2021-2026
• Rest of World (ROW) - size and forecast 2021-2026

To know about the contribution of each segment - Grab an Exclusive Sample Report

Don't wait, Make a strategic approach & boost your business goals with our Pharmacovigilance and Drug Safety Software Market Forecast Report - Buy Now!

Related Reports:

• The predicted growth of the healthcare information software market share from 2021 to 2026 is USD 11.76 billion at a progressing CAGR of 7.9%. Download a sample now!
• The cancer registry software market share is expected to increase by USD 54.20 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 11.19%. Download a sample now!

Table of Content

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

• 5.1 Market segments
• Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
• Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)

• 5.2 Comparison by End-user
• Exhibit 26: Chart on Comparison by End-user
• Exhibit 27: Data Table on Comparison by End-user

• 5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
• Exhibit 28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)

• 5.4 Contract research organization - Market size and forecast 2021-2026
• Exhibit 32: Chart on Contract research organization - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Contract research organization - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Contract research organization - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Contract research organization - Year-over-year growth 2021-2026 (%)

• 5.5 Business process outsourcing - Market size and forecast 2021-2026
• Exhibit 36: Chart on Business process outsourcing - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Business process outsourcing - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Business process outsourcing - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Business process outsourcing - Year-over-year growth 2021-2026 (%)

• 5.6 Market opportunity by End-user
• Exhibit 40: Market opportunity by End-user ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 42: Chart on Market share by geography 2021-2026 (%)
• Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 France - Market size and forecast 2021-2026
• Exhibit 66: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on France - Year-over-year growth 2021-2026 (%)

• 7.9 Germany - Market size and forecast 2021-2026
• Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.10 Japan - Market size and forecast 2021-2026
• Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.11 China - Market size and forecast 2021-2026
• Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 88: Matrix on vendor position and classification

• 10.3 AB Cube SARL
• Exhibit 89: AB Cube SARL - Overview
• Exhibit 90: AB Cube SARL - Product / Service
• Exhibit 91: AB Cube SARL - Key offerings

• 10.4 ArisGlobal LLC
• Exhibit 92: ArisGlobal LLC - Overview
• Exhibit 93: ArisGlobal LLC - Product / Service
• Exhibit 94: ArisGlobal LLC - Key offerings

• 10.5 BaseCon AS
• Exhibit 95: BaseCon AS - Overview
• Exhibit 96: BaseCon AS - Product / Service
• Exhibit 97: BaseCon AS - Key offerings

• 10.6 Ennov
• Exhibit 98: Ennov - Overview
• Exhibit 99: Ennov - Product / Service
• Exhibit 100: Ennov - Key news
• Exhibit 101: Ennov - Key offerings

• 10.7 EXTEDO GmbH
• Exhibit 102: EXTEDO GmbH - Overview
• Exhibit 103: EXTEDO GmbH - Product / Service
• Exhibit 104: EXTEDO GmbH - Key news
• Exhibit 105: EXTEDO GmbH - Key offerings

• 10.8 Honeywell International Inc.
• Exhibit 106: Honeywell International Inc. - Overview
• Exhibit 107: Honeywell International Inc. - Business segments
• Exhibit 108: Honeywell International Inc. - Key news
• Exhibit 109: Honeywell International Inc. - Key offerings
• Exhibit 110: Honeywell International Inc. - Segment focus

• 10.9 Indegene Pvt. Ltd.
• Exhibit 111: Indegene Pvt. Ltd. - Overview
• Exhibit 112: Indegene Pvt. Ltd. - Product / Service
• Exhibit 113: Indegene Pvt. Ltd. - Key news
• Exhibit 114: Indegene Pvt. Ltd. - Key offerings

• 10.10 Oracle Corp.
• Exhibit 115: Oracle Corp. - Overview
• Exhibit 116: Oracle Corp. - Business segments
• Exhibit 117: Oracle Corp. - Key news
• Exhibit 118: Oracle Corp. - Key offerings
• Exhibit 119: Oracle Corp. - Segment focus

• 10.11 Sarjen Systems Pvt. Ltd.
• Exhibit 120: Sarjen Systems Pvt. Ltd. - Overview
• Exhibit 121: Sarjen Systems Pvt. Ltd. - Product / Service
• Exhibit 122: Sarjen Systems Pvt. Ltd. - Key offerings

• 10.12 United BioSource LLC
• Exhibit 123: United BioSource LLC - Overview
• Exhibit 124: United BioSource LLC - Product / Service
• Exhibit 125: United BioSource LLC - Key offerings

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 126: Inclusions checklist
• Exhibit 127: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 128: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 129: Research methodology
• Exhibit 130: Validation techniques employed for market sizing
• Exhibit 131: Information sources

• 11.5 List of abbreviations
• Exhibit 132: List of abbreviations

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio